Ruxolitinib cream for the treatment of cutaneous sarcoidosis
JAAD Case Rep
.
2023 Jun 3:38:111-112.
doi: 10.1016/j.jdcr.2023.05.032.
eCollection 2023 Aug.
Authors
Jeffrey S Smith
1
2
3
4
5
,
Michael J Woodbury
1
5
,
Joseph F Merola
1
5
Affiliations
1
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
2
Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
3
Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
4
Dermatology Program, Boston Children's Hospital, Boston, Massachusetts.
5
Harvard Medical School, Boston, Massachusetts.
PMID:
37521191
PMCID:
PMC10372038
DOI:
10.1016/j.jdcr.2023.05.032
No abstract available
Keywords:
JAK inhibitors; cutaneous sarcoidosis; ruxolitinib.
Publication types
Case Reports